Khan Zaid, Khursheed Syed Quibtiya, Dar Shabir Ahmad, Shah Naveed Nazir, Reagu Shuja, Alabdulla Majid, Haq Inaamul, Ud Din Azad Aaliya Mohi, Dar Khurshid Ahmad, Farooq Syed Suraiya, Wani Zaid Ahmad
Department of Pulmonary Medicine, Government Chest Diseases Hospital, Srinagar, Jammu and Kashmir, India.
Department of surgery, SKIMS Medical College, Srinagar, Jammu and Kashmir, India.
J Educ Health Promot. 2022 Feb 26;11:59. doi: 10.4103/jehp.jehp_642_21. eCollection 2022.
Vaccine hesitancy is seen, globally, as a major factor that will determine future coronavirus disease-19 (COVID-19) spread and its effective management. This study aimed to identify COVID-19 vaccine perception, acceptance, confidence, hesitancy, and barriers among the general population.
This was an online survey which was developed and shared through social media platforms among the general population of Kashmir. The survey captured demographic data and used a validated hesitancy measurement tool. We analyzed the data using descriptive statistics and multivariable logistic regression using Stata 15 (Stata Corp. 2017. Stata Statistical Software: Release 15. College Station, TX, USA: Stata Corp LLC).
A total of 835 responses were received. Most participants were males, with females compromising of 19.5% participants. 65.1% of participants were in the age group of 30-50, whereas 19.2% were below 30 years of age. 52.70% of respondents were willing to take the vaccine when available, while 32.5% of respondents were unsure about their decision of inoculation. The most cited reason for willingness to get vaccinated was an understanding of the disease and vaccination. 41.70% felt that the vaccines developed against COVID-19 have not been fully tested; therefore, concerns around the safety and its longer-term side effects were the reasons cited. Public health messaging should be tailored to address these concerns.
Vaccine hesitancy is a global threat undermining the control of preventable infections. The government should take proactive steps to address the factors that may potentially impact the benefits expected from the introduction of a COVID-19 vaccine in the union territory.
在全球范围内,疫苗犹豫被视为决定未来冠状病毒病2019(COVID - 19)传播及其有效管理的一个主要因素。本研究旨在确定普通人群对COVID - 19疫苗的认知、接受程度、信心、犹豫情况及障碍。
这是一项在线调查,通过社交媒体平台在克什米尔普通人群中开展并分享。该调查收集了人口统计学数据,并使用了经过验证的犹豫测量工具。我们使用描述性统计和Stata 15进行多变量逻辑回归分析数据(Stata公司。2017年。Stata统计软件:第15版。美国得克萨斯州大学站:Stata公司有限责任公司)。
共收到835份回复。大多数参与者为男性,女性占参与者的19.5%。65.1%的参与者年龄在30 - 50岁之间,而19.2%的参与者年龄在30岁以下。52.70%的受访者在有疫苗时愿意接种,而32.5%的受访者对其接种决定不确定。愿意接种疫苗最常被提及的原因是对疾病和疫苗接种的了解。41.70%的人认为针对COVID - 19研发的疫苗尚未经过充分测试;因此,对安全性及其长期副作用的担忧是被提及的原因。公共卫生信息传递应针对这些担忧进行调整。
疫苗犹豫是一个破坏可预防感染控制的全球威胁。政府应采取积极措施,解决可能潜在影响在该联邦属地引入COVID - 19疫苗所期望获得的益处的因素。